021-51111890
购物车（）
sales@molnova.cn
KKI-5
CAS No. 97145-43-2
KKI-5 ( —— )
产品货号. M30490 CAS No. 97145-43-2
KKI 5 is a serine protease inhibitor that inhibits kallikrein and plasmin. KKI 5 may exhibit anticancer chemotherapeutic benefit and may also be used as a treatment for angioedema.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ￥1260 | 有现货 |
|
| 10MG | ￥2268 | 有现货 |
|
| 100MG | 获取报价 | 有现货 |
|
| 200MG | 获取报价 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 5MG | ￥1260 | 有现货 |
|
| 10MG | ￥2268 | 有现货 |
|
| 100MG | 获取报价 | 有现货 |
|
| 200MG | 获取报价 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
生物学信息
-
产品名称KKI-5
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述KKI 5 is a serine protease inhibitor that inhibits kallikrein and plasmin. KKI 5 may exhibit anticancer chemotherapeutic benefit and may also be used as a treatment for angioedema.
-
产品描述KKI 5 is a serine protease inhibitor that inhibits kallikrein and plasmin. KKI 5 may exhibit anticancer chemotherapeutic benefit and may also be used as a treatment for angioedema.(In Vitro):The KKI-5 Peptide corresponds to aa386-391 of bovine kininogen-1 that encompasses the aa388-389 kallikrein proteolytic site. The synthetic KKI-5 can attenuate breast cancer cell invasion, therefore it is investigated for its role in invasion and metastasis of cancer cells.
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体Kallikrein Inhibitor
-
研究领域——
-
适应症——
化学信息
-
CAS Number97145-43-2
-
分子量773.9
-
分子式C35H55N11O9
-
纯度>98% (HPLC)
-
溶解度——
-
SMILES——
-
化学全称Sequence:Ac-Pro-Phe-Arg-Ser-Val-Gln-NH2
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
Deshpande MS, et al. Mapping the binding site of tissue kallikrein: preparation and testing of all possible substrate analog inhibitors homologous with the sequence of kininogen between Ser386 and Gln392. J Med Chem. 1992 Aug 21;35(17):3094-102.
产品手册
关联产品
-
Bovinocidin
Bovinocidin is an irreversible inhibitor of succinate dehydrogenase.
-
Bergamjuicin
Bergamjuicin is a flavonoid isolated from Citrus grandis L. Osbeck with cellular antioxidant activity (CAA) and oxygen radical absorption capacity (ORAC).
-
PACAP-38 (16-38), hu...
PACAP-38 (16-38), human, mouse, rat demonstrates potent, efficacious, and sustained stimulatory effects on sympathetic neuronal NPY and catecholamine production.
